[Inhaled bronchodilators and mucolytic agents in cystic fibrosis].

P, Le Roux; B, Le Luyer

Found an issue? Give us feedback

Archives de Pédiatri...arrow_drop_down

Archives de Pédiatrie

Article . 2004

Data sources: Europe PubMed Central

[Inhaled bronchodilators and mucolytic agents in cystic fibrosis].

descriptionPublicationkeyboard_double_arrow_right Article 08 Jan 2004 French Journal:Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, volume 10 Suppl 2 (issn: 0929-693X,

Copyright policy )

Authors: P, Le Roux; B, Le Luyer;

pmid: 14671935

[Inhaled bronchodilators and mucolytic agents in cystic fibrosis].

- Summary
- Subjects
- Metrics

Abstract

Poor clearance of airway secretions contributes to the pulmonary disease in cystic fibrosis (CF). Bronchodilator therapy might benefit in CF, but the efficacy is controversial. Effects of mucolytic agents have not been demonstrated conclusively. Only, efficacy of recombinant human deoxyribonuclease (rhDNase) is established with a rapid onset of benefit.

Keywords

Deoxyribonucleases, Cystic Fibrosis, Administration, Inhalation, Humans, Recombinant Proteins, Bronchodilator Agents, Expectorants

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	2
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average